Startup Clerkenwell Health hopes to help make UK a world leader in psychedelics research
Europe’s first commercial facility for psychedelic drug trials is to open in London, with the goal of making the UK a global leader in psychedelics research and innovation.
The British startup Clerkenwell Health aims to begin trials in its central London facility in August, initially focusing on the use of psilocybin to help people deal with the anxiety associated with a diagnosis of terminal illness, and to support them through their end-of-life care.
Nice post. I learn something new and challenging on blogs I stumbleupon on a daily basis. https://yoykem.com.tr/
Your writing style is exceptional. I enjoyed reading this article and appreciated the way you presented the information in an engaging and thought-provoking manner.
I like how you present the information in an easy to understand and structured way.
Your article was an enjoyable read. You have a way of making even dry topics interesting.